about
EGFR inhibition abrogates leiomyosarcoma cell chemoresistance through inactivation of survival pathways and impairment of CSC potentialSpatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cellsRole of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cellsTyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancerMek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association.Caveolin-1 tumor-promoting role in human melanomaLipid raft disruption protects mature neurons against amyloid oligomer toxicity.cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes.Propranolol promotes Egr1 gene expression in cardiomyocytes via beta-adrenoceptors.Cell Propagation of Cholera Toxin CTA ADP-Ribosylating Factor by Exosome Mediated Transfer.Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic moleculesTfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathwayCaveolin-1 Endows Order in Cholesterol-Rich Detergent Resistant MembranesA new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
P50
Q28484249-D15300D4-AE34-41C5-AB4D-5115008BAD2FQ28506688-36424BA7-8602-469E-AE02-42D1F83DBA84Q30865013-DF4DB8FE-9B1D-429D-8F43-D1F4425B600CQ36022297-25F80B1A-F50D-4ED5-BBCE-B75CBD91FC2BQ37418121-3B483E55-E264-4E14-AFC4-831D8E2A5EFEQ39568935-F218675B-C2BC-4670-ABBD-2D36B3E7412FQ39838942-90BA43BA-E29A-4D2E-8AE2-9475B51E1047Q42830589-9165C64E-BA62-4EBF-A627-6C43455695CEQ46318982-1103F207-7522-4C67-8EC7-62E862C5F02FQ46591491-C74716F2-E9CF-45A5-9A7E-AB60B35F8675Q54956421-2CCF4D39-3B42-4CE9-A822-DA89114D11ACQ57022201-D4C82253-78B7-4365-9D6C-5865DADEC3F9Q57375296-6CFBDFE5-758E-4963-BE8B-D7ABDCDAEEA8Q91994968-4D389095-A93C-4DFF-9C81-64B56CBE00EAQ92091998-B0270214-AAC7-4A34-A2CD-9C8EEA653023
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Katia Fecchi
@ast
Katia Fecchi
@en
Katia Fecchi
@es
Katia Fecchi
@nl
Katia Fecchi
@sl
type
label
Katia Fecchi
@ast
Katia Fecchi
@en
Katia Fecchi
@es
Katia Fecchi
@nl
Katia Fecchi
@sl
prefLabel
Katia Fecchi
@ast
Katia Fecchi
@en
Katia Fecchi
@es
Katia Fecchi
@nl
Katia Fecchi
@sl
P1053
N-1380-2017
P106
P1153
24175960000
P21
P31
P3829
P496
0000-0003-4397-5783